• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, June 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Breakthrough T cell discovery has huge potential for engineering custom immune responses

Bioengineer by Bioengineer
October 25, 2023
in Biology
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

SEATTLE – T cells are soldiers on the front lines of the human immune system. They are responsible for many important roles, including attacking viral- or bacterial-infected cells and certain cancer cells, and immunological memory – remembering the specific pathogens or the cancer signatures that originally trigger T cells. 

Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses

Credit: Video courtesy of ISB

SEATTLE – T cells are soldiers on the front lines of the human immune system. They are responsible for many important roles, including attacking viral- or bacterial-infected cells and certain cancer cells, and immunological memory – remembering the specific pathogens or the cancer signatures that originally trigger T cells. 

Until now, understanding how a T cell forms into a specific role, for example a cell-killing (cytotoxic) T cell or memory T cell, has eluded us. In a paper that will be published online by Cell Reports on October 25, ISB researchers made the breakthrough discovery that the genetically encoded T-cell receptor (TCR) sequence that humans develop in early childhood determines a T cell’s function. 

“That receptor sequence is the major determinant – not signaling proteins such as cytokines or other blood components,” said Daniel Chen, first author of the paper. “It is that receptor sequence – the proteins on the T cell that bind to foreign antigens – that determines what this cell’s phenotype is, and thus determines what its function is going to be.”

In a human clinical study involving 68 patients, the team explored around 700 T cells that specifically interacted with antigens from either SARS-CoV-2, influenza, or cytomegalovirus.  

The potential of this fundamental discovery is promising for developing custom immune responses to specific antigens. 

“T-cell receptor-engineered T cell cancer immunotherapies are an emerging treatment for solid tumors. In such therapies, the T cells that comprise the drug are typically engineered to aggressively kill cancer cells. We know that a successful immune response requires a balance of T cell phenotypes, some of which kill tumor cells, but others which can form memory or do other functions,” said ISB President and Professor Dr. James R. Heath, corresponding author of the paper.

“We show that there is basically a card catalog available,” Heath added. “If you want to engineer a balanced immune response, you go to that card catalog, you find the particular TCR genes that, when engineered to build the cell therapy, can provide that balanced response.”

A different “card catalog” is required for different antigens. However, many antigens are immunogenic, meaning that for different patients afflicted with the same disease, their T cells will often target the same antigen.

“This is important,” said Chen, “because it means that what we learn for one patient is likely going to be applicable for another.”

This work was funded by the WA State Andy Hill CARE Foundation, by the National Cancer Institute, and by the Parker Institute for Cancer Immunotherapy. 

About ISB
Institute for Systems Biology (ISB) is a collaborative and cross-disciplinary non-profit biomedical research organization based in Seattle. We focus on some of the most pressing issues in human health, including aging, brain health, cancer, COVID-19, the human microbiome, as well as many infectious diseases. Our science is translational, and we champion sound scientific research that results in real-world clinical impacts. ISB is an affiliate of Providence, one of the largest not-for-profit health care systems in the United States. Follow us online at isbscience.org, and on YouTube, Facebook, Instagram, LinkedIn and Twitter.



Journal

Cell Reports

DOI

10.1016/j.celrep.2023.113279

Method of Research

Randomized controlled/clinical trial

Subject of Research

People

Article Title

T cell receptor sequences are the dominant factor contributing to the phenotype of CD8+ cells with specificities against immunogenic viral antigens

Article Publication Date

25-Oct-2023

Share12Tweet8Share2ShareShareShare2

Related Posts

Tumor Growth

Targeting Pol 1 Reprograms Cancer Cells to Inhibit Tumor Growth

June 18, 2025
Illustration

Uncovering Microbial Rhythms: A Novel Target Emerges for Metabolic Disease Treatment

June 18, 2025

Breakthrough in Mass Production of Artificial Cells with Model Nuclei Achieved Using Microfluidic Devices

June 18, 2025

Social Influences Shape Our Perceptions of Animal Intelligence

June 18, 2025

POPULAR NEWS

  • Green brake lights in the front could reduce accidents

    Study from TU Graz Reveals Front Brake Lights Could Drastically Diminish Road Accident Rates

    161 shares
    Share 64 Tweet 40
  • New Study Uncovers Unexpected Side Effects of High-Dose Radiation Therapy

    76 shares
    Share 30 Tweet 19
  • Pancreatic Cancer Vaccines Eradicate Disease in Preclinical Studies

    71 shares
    Share 28 Tweet 18
  • How Scientists Unraveled the Mystery Behind the Gigantic Size of Extinct Ground Sloths—and What Led to Their Demise

    65 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Imaging Breakthroughs Reveal Early Parkinson’s Signs

Navigating New Frontiers: ESG Lending and Tech Investments Propel Stability and Growth in BRICS Banks

Breakthrough in 30-Year Micronutrient Mystery Paves Way for Innovative Medical Research

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.